Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$221.92 - $245.94 $770,728 - $854,149
-3,473 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$219.9 - $263.41 $21,990 - $26,341
-100 Reduced 2.8%
3,473 $831,000
Q4 2019

Feb 12, 2020

SELL
$236.45 - $266.82 $23,645 - $26,682
-100 Reduced 2.72%
3,573 $972,000
Q3 2019

Nov 05, 2019

SELL
$230.58 - $256.08 $461 - $512
-2 Reduced 0.05%
3,673 $929,000
Q2 2019

Aug 08, 2019

SELL
$217.4 - $246.08 $10,870 - $12,304
-50 Reduced 1.34%
3,675 $926,000
Q4 2018

Feb 11, 2019

BUY
$204.73 - $257.93 $366,466 - $461,694
1,790 Added 92.51%
3,725 $839,000
Q3 2018

Nov 06, 2018

SELL
$233.07 - $256.0 $40,787 - $44,800
-175 Reduced 8.29%
1,935 $505,000
Q2 2018

Aug 02, 2018

BUY
$208.1 - $233.85 $439,091 - $493,423
2,110 New
2,110 $505,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Capital Management Associates Portfolio

Follow Capital Management Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Associates , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Associates with notifications on news.